InnoMedCatalyst Launches Accelerator Programme for MedTech and HealthTech Innovators

InnoMedCatalyst Consortium, focused on catalysing the regional innovation capacity of the Digital Precision Medicine ecosystem and beyond, is proud to announce the launch of its Pan-European InnoMedCatalyst Accelerator Programme.

This transformative programme is designed to support MedTech and HealthTech startups, spin-offs, and early-stage SMEs in levelling up their innovative solutions, with a focus on digital personalised, predictive, preventive, participatory, and precision healthcare.

The accelerator welcomes innovators to the dynamic InnoMedCatalyst community where they can advance their path to market with tailored guidance. Through one-on-one mentoring, expert-led webinars, and access to a vast network of over 150 partners, investors, and mentors across Europe, participants will gain the right support to take their innovative solutions and products to the next level and to create a lasting impact within the industry.

Accelerator Programme and final Demo Day:

The programme is tailored for innovators whose technologies are in the testing and validation phase within clinical settings, following a regulated pathway to market. We are particularly looking for innovations that will have a tangible impact on health and are determined to transform the medical ecosystem.

On November 14, 2025, at the end of the acceleration programme, a final Demo Day will be held in Bologna. During this event, the selected startups will have the opportunity to present their projects to a panel of investors and industry experts, in a dedicated showcase moment designed to highlight the results achieved throughout the programme and to foster concrete opportunities for growth and investment.

Eligibility Criteria:

1. Early-stage spinoffs, startups, or SMEs in MedTech or HealthTech,
2. Focus on innovations in the digital personalised, predictive, preventive, participatory, and precision healthcare space,
3. Technologies with a TRL (Technology Readiness Level) of 4-6,
4. Innovators based in Belgium, Bulgaria, Greece, Italy, Poland, Portugal, Romania, or Spain.

This is a unique opportunity for changemakers eager to scale their impact and drive forward the future of healthcare.

How to candidate:

The application process is through the Life Science Open Space, a platform dedicated to fostering innovation, collaboration, and advancement within the life sciences industry.
It connects individuals such as researchers, entrepreneurs, investors, and industry experts to enable knowledge exchange, cutting-edge projects, and partnership opportunities. Being part of this community allows meaningful collaborations, exploration of emerging trends, and contribution to shaping the future of life sciences.

Applications are now open until May 20, and InnoMedCatalyst consortium invites eligible innovators to apply and join a powerful network ready to accelerate their growth.

Apply now and become part of the transformative journey to shape the future of healthcare!

To submit your application, visit the dedicated page: Life Science Open Space

Download the programme here: